Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Sue-jean Lin

Director at Arcutis Biotherapeutics, Inc. (ARQT)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $898K

Reported trades

Filed Stock Type Shares Price Value Since
Jun 17SEC ARQTArcutis Biotherapeutics, Inc. Sell Plan 4,94627,567 held (−15%) $24.38 $121K +18.2%
Nov 25SEC ARQTArcutis Biotherapeutics, Inc. Sell 25,27226,735 held (−49%) $30.78 $778K -6.4%
  • Sell

    Director Sue-jean Lin sold $121K of ARQT at $24.38 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Sue-jean Lin sold $778K of ARQT at $30.78 — cuts the stake by 49%.